Scientists test new strategy for One-Shot flu protection

NCT ID NCT03816878

Summary

This early-stage study explored a new vaccination strategy aimed at creating broader protection against multiple flu strains, potentially moving toward a 'universal' flu vaccine. Researchers tested an H5N1 flu shot in 32 healthy adults, comparing those who had received previous experimental flu vaccines with those who hadn't. The main goal was to measure immune responses and safety over one year to see if this 'prime-boost' approach could teach the immune system to recognize parts of the virus common to many flu strains.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLUENZA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health

    Baltimore, Maryland, 21205, United States

Conditions

Explore the condition pages connected to this study.